Frequency of creatine kinase elevation during treatment with fluvastatin

American Journal of Cardiology

Volumn 89, Issue 2, 2002, Pages 231-233

  Benghozi, Renee ^a   Bortolini, Michele ^a   Jia, Yan ^a   Isaacsohn, Jonathan L ^a   Troendle, August J ^b   Gonasun, Leonard ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Novartis Pharmaceuticals Corporation ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; CREATINE KINASE; FLUINDOSTATIN; MEVINOLIN;

ADULT; AGE; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG RELEASE; DRUG SAFETY; FEMALE; GENDER; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PRIORITY JOURNAL; PROTEIN BINDING; RESTENOSIS;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CREATINE KINASE; DELAYED-ACTION PREPARATIONS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; INDOLES; MALE; MIDDLE AGED;

EID: 0037081636     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02209-3     Document Type: Article

References (9)

1. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The Cholesterol and Recurrent Events trial (CARE)
3. Current perspectives on statins
4. The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment
5. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: Final results of the fluvastatin angiographic restenosis (FLARE) trial
6. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])
7. Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
8. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia
9. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: The pivotal placebo-controlled clinical trial